|
GB191115253A
(en)
|
1911-06-30 |
1912-06-20 |
Adolph Schneider |
Improvements in Bottle-filling Machines.
|
|
US2382696A
(en)
|
1939-04-01 |
1945-08-14 |
Milleville Marie Joseph Mau De |
Method and apparatus for filling containers
|
|
GB684057A
(en)
|
1949-11-30 |
1952-12-10 |
Stockholms Bryggerier Ab |
Machine of the rotatory table type for the treatment of bottles and the like containers
|
|
US2699718A
(en)
|
1952-04-10 |
1955-01-18 |
Francis X Wright |
Filling apparatus with beverage preparation mechanism
|
|
FR1418965A
(fr)
|
1964-10-14 |
1965-11-26 |
Chelle Ets |
Tireuse de liquides à double utilisation
|
|
AU554222B2
(en)
|
1981-10-13 |
1986-08-14 |
Toyo Garasu K.K. |
Inspecting glass containers
|
|
DE59108644D1
(de)
|
1990-07-02 |
1997-05-07 |
Hoechst Ag |
Oligonucleotid-analoge mit terminalen 3'-3'-bzw. 5'-5'-Internucleotidverknüpfungen
|
|
ATE227342T1
(de)
|
1993-09-02 |
2002-11-15 |
Ribozyme Pharm Inc |
Enzymatische nukleiksaüre die nicht-nukleotide enthaltet
|
|
WO1995026204A1
(en)
|
1994-03-25 |
1995-10-05 |
Isis Pharmaceuticals, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
|
US20030050263A1
(en)
|
1994-07-15 |
2003-03-13 |
The University Of Iowa Research Foundation |
Methods and products for treating HIV infection
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
FR2732971B1
(fr)
|
1995-04-13 |
1997-07-04 |
Genset Sa |
Oligonucleotide sens inhibiteur de virus herpes simplex (hsv) a structure en haltere
|
|
US5856462A
(en)
|
1996-09-10 |
1999-01-05 |
Hybridon Incorporated |
Oligonucleotides having modified CpG dinucleosides
|
|
ATE238328T1
(de)
|
1996-10-16 |
2003-05-15 |
Ribapharm Inc |
Monozyklische l-nukleoside, analoga und ihre anwendungen
|
|
DE19648625A1
(de)
|
1996-11-13 |
1998-05-14 |
Soft Gene Gmbh |
Mikroprojektil für das Einbringen von Substanzen in Zellen durch ballistischen Transfer
|
|
EP0855184A1
(en)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
|
US6251666B1
(en)
|
1997-03-31 |
2001-06-26 |
Ribozyme Pharmaceuticals, Inc. |
Nucleic acid catalysts comprising L-nucleotide analogs
|
|
US6589940B1
(en)
|
1997-06-06 |
2003-07-08 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
|
US6192481B1
(en)
|
1998-08-18 |
2001-02-20 |
International Business Machines Corporation |
Structure and method for power sequencing of disk drives in a computer system
|
|
CA2371994C
(en)
|
1999-02-26 |
2010-09-28 |
Guido Grandi |
Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs
|
|
US6977245B2
(en)
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
|
US6737066B1
(en)
|
1999-05-06 |
2004-05-18 |
The Immune Response Corporation |
HIV immunogenic compositions and methods
|
|
AU5821000A
(en)
|
1999-06-29 |
2001-01-31 |
Smithkline Beecham Biologicals (Sa) |
Vaccine
|
|
DE19935756A1
(de)
|
1999-07-27 |
2001-02-08 |
Mologen Forschungs Entwicklung |
Kovalent geschlossenes Nukleinsäuremolekül zur Immunstimulation
|
|
AU1656601A
(en)
|
1999-11-12 |
2001-06-12 |
Isis Pharmaceuticals, Inc. |
Gapped oligomers having site specific chiral phosphorothioate internucleoside linkages
|
|
AU2001294750C1
(en)
|
2000-09-26 |
2008-09-18 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
|
|
EP1355661A2
(de)
|
2001-01-31 |
2003-10-29 |
Mologen Forschungs-, Entwicklungs- und Vertriebs GmbH |
Tumorvakzine
|
|
CA2452458A1
(en)
|
2001-07-03 |
2003-01-16 |
Isis Pharmaceuticals, Inc. |
Nuclease resistant chimeric oligonucleotides
|
|
ES2242888T3
(es)
|
2001-10-02 |
2005-11-16 |
Mologen Ag |
Constructo de expresion de adn para el tratamiento de infecciones por leishmaniosis.
|
|
EP1432439B1
(de)
|
2001-10-02 |
2005-12-07 |
Mologen AG |
Mittel zur verbesserung der immunantwort
|
|
US7276489B2
(en)
|
2002-10-24 |
2007-10-02 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
|
|
WO2003035836A2
(en)
|
2001-10-24 |
2003-05-01 |
Hybridon Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
|
|
JP2003204793A
(ja)
|
2002-01-15 |
2003-07-22 |
Takeda Chem Ind Ltd |
ウイルス性疾患の予防または治療剤
|
|
DE10211558A1
(de)
|
2002-03-15 |
2003-10-09 |
Noxxon Pharma Ag |
Neue Formen RNAi
|
|
US7605138B2
(en)
*
|
2002-07-03 |
2009-10-20 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
US20040248837A1
(en)
|
2002-11-01 |
2004-12-09 |
Eyal Raz |
Methods of treating pulmonary fibrotic disorders
|
|
US8158768B2
(en)
|
2002-12-23 |
2012-04-17 |
Dynavax Technologies Corporation |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
|
US7501503B2
(en)
|
2002-12-31 |
2009-03-10 |
Mcgill University |
Compositions and methods for inhibiting RNase H activity of retroid reverse transcriptase
|
|
AU2004224761A1
(en)
|
2003-03-26 |
2004-10-07 |
Cytos Biotechnology Ag |
HIV-peptide-carrier-conjugates
|
|
WO2004111247A1
(de)
|
2003-06-10 |
2004-12-23 |
Mologen Ag |
Zirkuläres expressionskonstrukt für gentherapeutische anwendungen
|
|
EP1678303A2
(en)
|
2003-10-30 |
2006-07-12 |
Coley Pharmaceutical GmbH |
C-class oligonucleotide analogs with enhanced immunostimulatory potency
|
|
EP1691817A2
(en)
|
2003-12-02 |
2006-08-23 |
Corgentech, Inc. |
NF-kB OLIGONUCLEOTIDE DECOY MOLECULES
|
|
PL1699480T3
(pl)
|
2003-12-30 |
2011-11-30 |
Mologen Ag |
Allogeniczny przeciwnowotworowy czynnik terapeutyczny
|
|
WO2005080567A1
(de)
|
2004-02-20 |
2005-09-01 |
Mologen Ag |
Substituiertes, nicht-kodierendes nukleinsäuremolekül zur therapeutischen und prophylaktischen immunstimulation in menschen und höheren tieren
|
|
JP3976742B2
(ja)
|
2004-02-27 |
2007-09-19 |
江守商事株式会社 |
インターフェロンアルファを誘導する免疫刺激オリゴヌクレオチド
|
|
US20090004703A1
(en)
|
2004-05-28 |
2009-01-01 |
Mologen Ag |
Method for the Production of Suitable Dna Constructs for Specific Inhibition of Gene Expression by Rna Interference
|
|
JP4942646B2
(ja)
|
2004-06-15 |
2012-05-30 |
イデラ ファーマシューティカルズ インコーポレイテッド |
免疫賦活オリゴヌクレオチドマルチマー
|
|
WO2006015560A1
(de)
|
2004-08-09 |
2006-02-16 |
Mologen Ag |
Immunmodulierendes mittel in verbindung mit chemotherapeutischen massnahmen
|
|
US7879992B2
(en)
|
2005-01-31 |
2011-02-01 |
Isis Pharmaceuticals, Inc. |
Modification of MyD88 splicing using modified oligonucleotides
|
|
US7560436B2
(en)
|
2005-02-22 |
2009-07-14 |
The Regents Of The University Of California |
Methods of treating gastrointestinal inflammation
|
|
AU2006241149A1
(en)
|
2005-04-26 |
2006-11-02 |
Coley Pharmaceutical Gmbh |
Modified oligoribonucleotide analogs with enhanced immunostimulatory activity
|
|
KR20080065656A
(ko)
|
2005-10-12 |
2008-07-14 |
캔써 리서치 테크놀로지 리미티드 |
면역질환을 치료하기 위한 방법 및 조성물
|
|
EP2982679A1
(en)
|
2005-10-12 |
2016-02-10 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
|
|
AU2006315632A1
(en)
|
2005-11-11 |
2007-05-24 |
Pfizer, Inc. |
Combinations and methods of using an immunomodulatory oligodeoxynucleotide
|
|
RU2410431C2
(ru)
|
2005-11-25 |
2011-01-27 |
Мологен Аг |
Днк-конструкции для специфического ингибирования экспрессии генов посредством рнк-интерференции
|
|
JP4538522B2
(ja)
|
2005-11-25 |
2010-09-08 |
コーリー ファーマシューティカル ゲーエムベーハー |
免疫刺激性オリゴリボヌクレオチド
|
|
WO2007089871A2
(en)
|
2006-02-01 |
2007-08-09 |
The Johns Hopkins University |
Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
|
|
US9499815B1
(en)
*
|
2006-05-11 |
2016-11-22 |
Mologen Ag |
Multimer for immunostimulation
|
|
JP2009540016A
(ja)
|
2006-06-13 |
2009-11-19 |
ベイヒル セラピューティクス インコーポレーティッド |
疾患を予防および処置するための方法および免疫調節核酸組成物
|
|
PL2068918T5
(pl)
|
2006-09-26 |
2024-12-02 |
Access To Advanced Health Institute |
Kompozycja szczepionki zawierająca syntetyczny adiuwant
|
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
US20080260820A1
(en)
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
|
EP2333091B1
(en)
|
2007-05-29 |
2017-06-21 |
Nature Technology Corporation |
Vectors and methods for genetic immunization
|
|
CN103864893B
(zh)
|
2007-07-27 |
2017-01-04 |
伊玛提克斯生物技术有限公司 |
免疫疗法的免疫抗原表位
|
|
WO2009035554A2
(en)
|
2007-09-07 |
2009-03-19 |
University Of Florida Research Foundation, Inc. |
Superior structure stability and selectivity of hairpin nucleic acid probes with an l-dna stem
|
|
CN101820908A
(zh)
|
2007-10-09 |
2010-09-01 |
科利制药公司 |
包含改性糖部分的免疫刺激寡核苷酸类似物
|
|
EP2058397A1
(de)
|
2007-11-07 |
2009-05-13 |
Mologen AG |
Multimeres Assemblat zur Immunstimulation
|
|
WO2009069447A1
(ja)
|
2007-11-28 |
2009-06-04 |
Toray Industries, Inc. |
インフルエンザワクチン用のアジュバント及びインフルエンザワクチン
|
|
WO2009069682A1
(ja)
|
2007-11-28 |
2009-06-04 |
Toray Industries, Inc. |
肝炎の治療剤又は予防剤
|
|
WO2010039137A1
(en)
|
2008-10-02 |
2010-04-08 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
|
|
EP2246433A1
(de)
|
2009-04-30 |
2010-11-03 |
Mologen AG |
Concatemere zur Immunmodulation
|
|
MX2012011189A
(es)
|
2010-03-26 |
2013-02-07 |
Glaxosmithkline Biolog Sa |
Vacuna contra el virus e inmunodeficiencia humana.
|
|
GB201021867D0
(en)
|
2010-12-23 |
2011-02-02 |
Mologen Ag |
Non-coding immunomodulatory DNA construct
|
|
GB201021873D0
(en)
|
2010-12-23 |
2011-02-02 |
Mologen Ag |
DNA expression construct
|
|
JP5761707B2
(ja)
|
2011-02-02 |
2015-08-12 |
国立研究開発法人産業技術総合研究所 |
高効率細胞融合法
|
|
IN2014KN00920A
(https=)
*
|
2012-06-21 |
2015-10-09 |
Compugen Ltd |
|
|
GB2514591A
(en)
|
2013-05-30 |
2014-12-03 |
Mologen Ag |
Predictive biomarker for cancer therapy
|
|
GB2523187A
(en)
*
|
2014-02-18 |
2015-08-19 |
Mologen Ag |
Covalently closed non-coding immunomodulatory DNA construct
|
|
LU92821B1
(en)
*
|
2015-09-09 |
2017-03-20 |
Mologen Ag |
Combination comprising immunostimulatory oligonucleotides
|
|
GB2542425A
(en)
|
2015-09-21 |
2017-03-22 |
Mologen Ag |
Means for the treatment of HIV
|
|
EP3392345A1
(en)
|
2017-04-22 |
2018-10-24 |
Mologen AG |
Biomarker for small cell lung cancer therapy
|
|
EP3691749A1
(en)
|
2017-08-31 |
2020-08-12 |
Mologen AG |
Tlr-9 agonists for modulation of tumor microenvironment
|